Overview Fundamentals API Earnings EOD API Sample Code Pricing

PharmaCyte Biotech Inc (PMCB NASDAQ) stock market data APIs

$2.06 0.09(4.6%) as of July 18, 2024
Price chart is built with Anychart

PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer, as well as diabetes. The company is developing therapies for pancreatic and other solid cancerous tumors; a therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes, which include encapsulated genetically modified insulin-producing cells; and therapies for cancer based on the constituents of the cannabis plant. It has a research agreement with the University of Technology, Sydney to create a version of melligen cells to treat diabetes. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.

PharmaCyte Biotech Inc Financial Data Overview

1.97
2.06
-
2.06
1.97
1.76-2.84
17 414 K
8 453 K
0
-0.07
-0.187
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'PMCB',
Type: 'Common Stock',
Name: 'PharmaCyte Biotech Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000BBVY94',
ISIN: NULL,
CUSIP: NULL,
CIK: '1157075',
EmployerIdNumber: '62-1772151',
FiscalYearEnd: 'April',
IPODate: '2010-09-17',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

PharmaCyte Biotech Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA 0
  • Earnings Per Share -1.48
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get PharmaCyte Biotech Inc Earnings via APIs

  • Latest Release 2024-03-18
  • EPS/Forecast -0.07

Get PharmaCyte Biotech Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com